Urania Dafni

9PUBLICATIONS
106CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursEnvironmental epidemiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 17, 2026
Combinatorial Delivery of Low-Dose Radiotherapy and Immunotherapy to Patients with Immune-Excluded Tumors Enhances CD8+ T-cell Functionality.

|Sep 09, 2024
ctDNA Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or without Bevacizumab from the Randomized Phase II ETOP-BOOSTER Trial.

Ross A Soo, Urania Dafni, Ji-Youn Han

|Feb 02, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8+ T-myeloid cell networks in melanoma.

David Barras, Eleonora Ghisoni, Johanna Chiffelle

|Jan 25, 2024
Characteristics and Survival Outcomes of Patients With Metastatic RET Fusion-Positive Solid Tumors Receiving Non-RET Inhibitor Standards of Care in a Real-World Setting.

Allan Hackshaw, Otto Fajardo, Urania Dafni

|Nov 08, 2023
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study.

Diogo Martins-Branco, Marie Kassapian, Véronique Debien

|Sep 04, 2021
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.

Fernanda G Herrera, Catherine Ronet, Maria Ochoa de Olza

Pageof 2

Frequent Collaborators

3 joint publications

John Prior

3 joint publications

Denarda Dangaj Laniti

3 joint publications

Martina Imbimbo

3 joint publications

Maria Ochoa-de-Olza